With synthetic biology (synbio) rapidly gaining momentum, and a landmark US Supreme Court judgment striking down an age-old biological patenting system, biotechnology companies need to incorporate open-source into their innovation plans in order to succeed in the emerging landscape, according to Lux Research. (Business Standard)